NDLI: Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease

Please wait, while we are loading the content...

Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease

Content Provider	PubMed Central
Author	Rochester, Lynn Yarnall, Alison J. Baker, Mark R. David, Rachel V. Lord, Susan Brook, Galna Burn, David J.
Copyright Year	2012
Abstract	Gait disturbance is an early feature in Parkinson’s disease. Its pathophysiology is poorly understood; however, cholinergic dysfunction may be a non-dopaminergic contributor to gait. Short-latency afferent inhibition is a surrogate measure of cholinergic activity, allowing the contribution of cholinergic dysfunction to gait to be evaluated. We hypothesized that short-latency afferent inhibition would be an independent predictor of gait dysfunction in early Parkinson’s disease. Twenty-two participants with Parkinson’s disease and 22 age-matched control subjects took part in the study. Gait was measured objectively using an instrumented walkway (GAITRite), and subjects were asked to walk at their preferred speed for 2 min around a 25-m circuit. Spatiotemporal characteristics (speed, stride length, stride time and step width) and gait dynamics (variability described as the within subject standard deviation of: speed, stride time, stride length and step width) were determined. Short-latency afferent inhibition was measured by conditioning motor evoked potentials, elicited by transcranial magnetic stimulation of the motor cortex, with electrical stimuli delivered to the contralateral median nerve at intervals ranging from N20 (predetermined) to N20 + 4 ms. Short-latency afferent inhibition was determined as the percentage difference between test and conditioned response for all intervals and was described as the group mean. Participants were optimally medicated at the time of testing. Participants with Parkinson’s disease had significantly reduced gait speed (P = 0.002), stride length (P = 0.008) and stride time standard deviation (P = 0.001). Short-latency afferent inhibition was also significantly reduced in participants with Parkinson’s disease (P = 0.004). In participants with Parkinson’s disease, but not control subjects, significant associations were found between gait speed, short-latency afferent inhibition, age and postural instability and gait disorder score (Movement Disorders Society Unified Parkinson’s Disease Rating Scale) and attention, whereas global cognition and depression were marginally significant. No other gait variables were associated with short-latency afferent inhibition. A multiple hierarchical regression model explored the contribution of short-latency afferent inhibition to gait speed, controlling for age, posture and gait symptoms (Postural Instability and Gait Disorder score—Movement Disorders Society Unified Parkinson’s Disease Rating Scale), attention and depression. Regression analysis in participants with Parkinson’s disease showed that reduced short-latency afferent inhibition was an independent predictor of slower gait speed, explaining 37% of variability. The final model explained 72% of variability in gait speed with only short-latency afferent inhibition and attention emerging as independent determinants. The results suggest that cholinergic dysfunction may be an important and early contributor to gait dysfunction in Parkinson’s disease. The findings also point to the contribution of non-motor mechanisms to gait dysfunction. Our study provides new insights into underlying mechanisms of non-dopaminergic gait dysfunction, and may help to direct future therapeutic approaches.
Related Links	http://dx.doi.org/10.1093/brain/aws207
Ending Page	2788
Page Count	10
Starting Page	2779
File Format	PDF
ISSN	00068950
e-ISSN	14602156
Journal	Brain
Issue Number	9
Volume Number	135
Language	English
Publisher	Oxford University Press
Publisher Date	2012-09-01
Access Restriction	Open
Rights Holder	Oxford University Press
Subject Keyword	Clinical Neurology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Neurology (clinical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease

Cholinergic Dysfunction in Parkinson’s Disease

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease

Gait Disturbance Associated with Cholinergic Dysfunction in Early Parkinson's Disease

Effect of augmenting cholinergic function on gait and balance

Apathy and Olfactory Dysfunction in Early Parkinson’s Disease

Association of cognitive domains with postural instability/gait disturbance in Parkinson’s disease

Functional gait assessment in early and advanced Parkinson's disease

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease

Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease

Similar Documents

Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease

Cholinergic Dysfunction in Parkinson’s Disease

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease

Gait Disturbance Associated with Cholinergic Dysfunction in Early Parkinson's Disease

Effect of augmenting cholinergic function on gait and balance

Apathy and Olfactory Dysfunction in Early Parkinson’s Disease

Association of cognitive domains with postural instability/gait disturbance in Parkinson’s disease

Functional gait assessment in early and advanced Parkinson's disease

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease

Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease